Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Stereotaxis Inc. (STXS:NYSE), powered by AI.
Stereotaxis Inc. is currently trading at $1.82. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Stereotaxis Inc. on Alpha Lenz.
Stereotaxis Inc.'s P/E ratio is -7.6.
“Stereotaxis Inc. trades at a P/E of -7.6 (undervalued) with modest ROE of -143.6%.”
Ask for details →Stereotaxis Inc. is a cutting-edge medical technology company that specializes in robotic systems for minimally invasive surgery. The company's primary focus is on the development and commercialization of robotic navigation technologies designed to enhance the precision, safety, and efficiency of procedures within the cardiac arrhythmia treatment sector. Stereotaxis' flagship product, the Niobe Magnetic Navigation System, enables physicians to maneuver catheters with a high degree of accuracy, using magnetic fields to decrease potential complications associated with traditional manual techniques. This technology significantly impacts the healthcare sector, particularly hospitals and medical centers specializing in interventional cardiology, by improving patient outcomes and operational workflows. Based in St. Louis, Missouri, Stereotaxis plays a significant role in advancing the field of robotic surgery, contributing to the broader medical device market's growth and innovation.
“Stereotaxis Inc. trades at a P/E of -7.6 (undervalued) with modest ROE of -143.6%.”
Ask for details →Stereotaxis Inc. (ticker: STXS) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 139 employees. Market cap is $166M.
The current price is $1.82 with a P/E ratio of -7.65x and P/B of 8.84x.
ROE is -143.55% and operating margin is -68.30%. Annual revenue is $32M.